中国药物与临床2024,Vol.24Issue(2) :80-83.DOI:10.11655/zgywylc2024.02.003

低分子肝素预防子痫前期的作用机制及靶点

Mechanism and targets of low molecular heparin in the prevention of preeclampsia

任羽茜 胡丽燕
中国药物与临床2024,Vol.24Issue(2) :80-83.DOI:10.11655/zgywylc2024.02.003

低分子肝素预防子痫前期的作用机制及靶点

Mechanism and targets of low molecular heparin in the prevention of preeclampsia

任羽茜 1胡丽燕2
扫码查看

作者信息

  • 1. 山西医科大学附属山西省儿童医院妇产科,山西太原 030013
  • 2. 山西省儿童医院山西省妇幼保健院妇产科,山西太原 030013
  • 折叠

摘要

子痫前期是妊娠期特有的疾病,是全球孕产妇和围生期死亡的主要原因之一.本文通过查阅文献,综合分析低分子肝素(LMWH)在子痫前期预防和治疗中的作用及对妊娠结局的影响,为进一步研究和开发治疗子痫前期的药物提供新思路.结果发现,LMWH可能成为治疗子痫前期的新药物,可为子痫前期患者提供更有效和安全的治疗选择,促进母婴健康.

Abstract

A comprehensive review of the literature was conducted to analyze the exact role of low molec-ular heparin(LMWH)in the prevention and treatment of preeclampsia,as well as its effect on pregnancy out-comes.This review aims to offer novel insights for further research and development of therapeutic agents for preeclampsia.The findings suggest that LMWH could emerge as a promising therapeutic agent for preeclampsia,providing a potentially more effective and safe treatment option for patients.This,in turn,could significantly en-hance the well-being of mothers and infants.

关键词

子痫/肝素,低分子量/预防治疗

Key words

Eclampsia/Heparin,low-molecular-weight/Prevention and treatment

引用本文复制引用

出版年

2024
中国药物与临床
中国医院协会

中国药物与临床

影响因子:0.846
ISSN:1671-2560
参考文献量35
段落导航相关论文